Benlysta (belimumab) - GSK
Lupkynis (voclosporin) - Aurinia Pharma
Rituxan (rituximab) - Roche
Efficacy and safety of Belimumab, Rituximab and Voclosporin in the treatment of lupus nephritis based on registered clinical trials: A systematic review and network meta-analysis. (PubMed, Lupus) - Sep 8, 2025 - "Voclosporin had significantly better clinical efficacy than Rituximab during 1-year treatment period. Increasing the dose of Voclosporin did not significantly improve the efficacy, but it will increase the safety risk of adverse events." 
Clinical • Journal • Retrospective data • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology
http://www.ncbi.nlm.nih.gov/pubmed/40911722
 
Feigao Li; Menghao Li; Xinhui Zhang; Xiuju Liu; Xizhe Liu
 
Sep 8, 2025
 
Prev Next